Clinical Trial Update: Dacron vs Dardik for Fem-Pop Bypass [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Dacron and Dardik vascular grafts for femoropopliteal bypass has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Dacron
• Dardik

Snippet

Sponsor: Radboud University Medical Center | Conditions: Intermittent Claudication, Arterial Occlusive Diseases | Phase 3 | Status: COMPLETED